𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Emergence and clinical relevance of mutations associated with zidovudine resistance in asymptomatic HIV-1 infected patients

✍ Scribed by E. J. Calderón; Y. Torres; F. J. Medrano; F. Luque; B. Larder; C. Rey; A. Sánchez-Quijano; E. Lissen; M. Leal

Publisher
Springer
Year
1995
Tongue
English
Weight
955 KB
Volume
14
Category
Article
ISSN
0934-9723

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intermittent selection pressure with zid
Intermittent selection pressure with zidovudine plus zalcitabine treatment reduces the emergence in vivo of zidovudine resistance HIV mutations
✍ Izopet, J.; Sailler, L.; Sandres, K.; Pasquier, C.; Bonnet, E.; Aquilina, C.; Pu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 1 views

The development of mutations conferring drug resistance was investigated in 49 antiretroviralnaive asymptomatic HIV-1 subjects with CD4 + cell counts of 250-500/mm 3 given intermittent (6-week courses, 6 weeks apart) or continuous treatment with zidovudine (AZT) plus zalcitabine (ddC) over 54 weeks.

Saquinavir delays the emergence of zidov
Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy
✍ Andreoni, M.; Sarmati, L.; Nicastri, E.; Ventura, L.; Ercoli, L.; Parisi, S. G.; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 102 KB 👁 2 views

During a randomized double-blind study to assess the antiviral activity of saquinavir (SQV) alone or in combination with zidovudine (ZDV), the emergence of phenotypic resistance was evaluated in 44 patients treated with SQV (13 subjects), ZDV (14 subjects), and SQV plus ZDV (17 subjects). A signific

Diverse pattern of protease inhibitor re
Diverse pattern of protease inhibitor resistance mutations in HIV-1 infected patients failing nelfinavir
✍ Veronica Svedhem; A. Lindkvist; T. Bergroth; Lidman Knut; A. Sönnerborg 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract The aim of the study was to describe the pattern of resistance mutations in human immunodeficiency virus type 1 (HIV‐1) infected patients experiencing their first protease inhibitor (PI) failure on nelfinavir (NFV)‐containing therapy. Earlier PI‐naïve patients (n = 172) with NFV‐contain

An in-house HIV genotyping assay for the
An in-house HIV genotyping assay for the detection of drug resistance mutations in Southeast Asian patients infected with HIV-1
✍ Chun Kiat Lee; Hong Kai Lee; Tze Ping Loh; Sunil Kumar Sethi; Evelyn Siew-Chuan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

## Abstract Genotyping for HIV drug resistance is costly and beyond the means for many Southeast Asian patients, who are self‐funded. This prompted the development of a more cost‐effective, in‐house assay for an ethnically diverse, Southeast Asian population at the National University Hospital in S